# Investigate the Effect of Food on the Pharmacokinetic Characteristics of CKD-395 in Healthy Male Volunteers

> **NCT02648854** · PHASE1 · COMPLETED · sponsor: **Chong Kun Dang Pharmaceutical** · enrollment: 26 (actual)

## Conditions studied

- Diabetes Mellitus, Type II

## Interventions

- **DRUG:** CKD-395 0.5(Lobeglitazone)/1000(Metformin)mg 1T
- **DRUG:** CKD-395 0.5(Lobeglitazone)/1000(Metformin)mg 1T

## Key facts

- **NCT ID:** NCT02648854
- **Lead sponsor:** Chong Kun Dang Pharmaceutical
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-10
- **Primary completion:** 2015-10
- **Final completion:** 2015-11
- **Target enrollment:** 26 (ACTUAL)
- **Last updated:** 2016-02-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02648854

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02648854, "Investigate the Effect of Food on the Pharmacokinetic Characteristics of CKD-395 in Healthy Male Volunteers". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02648854. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*